MPLT

MAPLIGHT THERAPEUTICS INC

MPLT·56565P103·US·Common Stock·Healthcare - Biotechnology-Activist

MPLT (MAPLIGHT THERAPEUTICS INC) is held by 49 institutional investors as of Q1 2026. Largest holders: GOLDMAN SACHS GROUP INC ($40.6M), BlackRock, Inc. ($27.2M), VANGUARD CAPITAL MANAGEMENT LLC ($14.6M). Net institutional sentiment: Bullish.

49
Holders
Avg rating(10 Elite)
$158.7M
Total Value
71% (56)
Fund Consensus
34 buying - 14 selling
MPLTSmart Money Verdict
View all
Held by 49 funds
10 elite
Who's Trading
ActivistTRT. Rowe Price Investment Management, Inc.7.4%May 15, 2026
InsiderKAKroeger Christopher A.Sell $9KMay 11, 2026
InsiderKAKroeger Christopher A.Sell $25KMay 11, 2026
InsiderKAKroeger Christopher A.Sell $206KMay 11, 2026
InsiderKAKroeger Christopher A.Sell $180KMay 11, 2026
InsiderHKHanson KristopherSell $8KMay 11, 2026
InsiderHKHanson KristopherSell $24KMay 11, 2026
InsiderHKHanson KristopherSell $210KMay 11, 2026
InsiderHKHanson KristopherSell $177KMay 11, 2026
ActivistFGForbion Growth Opportunities Fund III Cooperatief U.A.7.1%Feb 17, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
2M(+3.0%)$40.6M0.0%+119.27%
30
Increased
1.3M(+22.3%)$27.2M0.0%+119.12%
35
New
719,820$14.6M0.0%+118.32%
39
Increased
481,201(+23.7%)$9.8M0.0%+119.11%
34
Unchanged
364,705$7.4M0.0%+119.30%
0
Increased
339,116(+47.8%)$6.9M0.0%+118.98%
37
Increased
313,957(+70.8%)$6.4M0.0%+118.89%
41
Increased
267,746(+81.0%)$5.4M0.0%+118.86%
42
New
248,294$5M0.1%+118.32%
37
Increased
236,512(+1193.1%)$4.8M0.0%+118.40%
43
Increased
204,501(+225x)$4.2M0.0%+118.33%
43
Increased
161,146(+16.4%)$3.3M0.0%+119.16%
31
Increased
146,172(+22.3%)$3M0.0%+119.12%
32
Decreased
142,016(-31.6%)$2.9M0.0%+119.30%
0
New
131,231$2.7M0.0%+118.32%
36
New
112,708$2.3M0.0%+118.32%
36
New
112,604$2.3M0.0%+118.32%
36
New
54,752$1.1M0.0%+118.32%
35
Increased
47,768(+29.2%)$971,1230.0%+119.08%
31
New
46,208$939,4090.0%+118.32%
35

Showing 1-20 of 56

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used